XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Additional paid in capital
Accumulated deficit
Accumulated other comprehensive income (loss)
Beginning balance (in shares) at Dec. 31, 2022   349.4      
Beginning balance at Dec. 31, 2022 $ (309.4) $ 0.0 $ 2,511.6 $ (2,772.1) $ (48.9)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Release of restricted stock units and awards (in shares)   11.5      
Shares withheld related to net share settlement of restricted stock units and awards (in shares)   (4.1)      
Shares withheld related to net share settlement of restricted stock units and awards (100.6)   (37.1) (63.5)  
Repurchases of common stock (in shares)   (18.8)      
Repurchases of common stock (436.1)   (170.7) (265.4)  
Exercise of stock options and awards (in shares)   0.2      
Exercise of stock options and awards 2.4   2.4    
Stock-based compensation 255.1   255.1    
Other comprehensive income 12.0       12.0
Net income 226.3     226.3  
Ending balance (in shares) at Sep. 30, 2023   338.2      
Ending balance at Sep. 30, 2023 (350.3) $ 0.0 2,561.3 (2,874.7) (36.9)
Beginning balance (in shares) at Jun. 30, 2023   339.6      
Beginning balance at Jun. 30, 2023 (411.9) $ 0.0 2,521.9 (2,895.6) (38.2)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Release of restricted stock units and awards (in shares)   3.5      
Shares withheld related to net share settlement of restricted stock units and awards (in shares)   (1.2)      
Shares withheld related to net share settlement of restricted stock units and awards (34.4)   (11.0) (23.4)  
Repurchases of common stock (in shares)   (3.8)      
Repurchases of common stock (104.4)   (34.6) (69.8)  
Exercise of stock options and awards (in shares)   0.1      
Exercise of stock options and awards 1.2   1.2    
Stock-based compensation 83.8   83.8    
Other comprehensive income 1.3       1.3
Net income 114.1     114.1  
Ending balance (in shares) at Sep. 30, 2023   338.2      
Ending balance at Sep. 30, 2023 (350.3) $ 0.0 2,561.3 (2,874.7) (36.9)
Beginning balance (in shares) at Dec. 31, 2023   336.7      
Beginning balance at Dec. 31, 2023 $ (165.8) $ 0.0 2,598.0 (2,742.3) (21.5)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Release of restricted stock units and awards (in shares)   10.8      
Shares withheld related to net share settlement of restricted stock units and awards (in shares) (4.2) (4.2)      
Shares withheld related to net share settlement of restricted stock units and awards $ (109.2)   (41.2) (68.0)  
Repurchases of common stock (in shares)   (37.0)      
Repurchases of common stock (895.6)   (363.4) (532.2)  
Exercise of stock options and awards 0.3   0.3    
Stock-based compensation 260.8   260.8    
Other comprehensive income 13.9       13.9
Net income 349.5     349.5  
Ending balance (in shares) at Sep. 30, 2024   306.3      
Ending balance at Sep. 30, 2024 (546.1) $ 0.0 2,454.5 (2,993.0) (7.6)
Beginning balance (in shares) at Jun. 30, 2024   318.7      
Beginning balance at Jun. 30, 2024 (371.3) $ 0.0 2,519.9 (2,872.6) (18.6)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Release of restricted stock units and awards (in shares)   3.7      
Shares withheld related to net share settlement of restricted stock units and awards (in shares)   (1.5)      
Shares withheld related to net share settlement of restricted stock units and awards (33.2)   (14.5) (18.7)  
Repurchases of common stock (in shares)   (14.6)      
Repurchases of common stock (351.8)   (143.4) (208.4)  
Exercise of stock options and awards 0.2   0.2    
Stock-based compensation 92.3   92.3    
Other comprehensive income 11.0       11.0
Net income 106.7     106.7  
Ending balance (in shares) at Sep. 30, 2024   306.3      
Ending balance at Sep. 30, 2024 $ (546.1) $ 0.0 $ 2,454.5 $ (2,993.0) $ (7.6)